| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.711 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.630 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.581 | |
| amine metabolic process | GO:0009308 | 45 | 0.521 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.519 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.460 | |
| stem cell development | GO:0048864 | 219 | 0.340 | |
| developmental maturation | GO:0021700 | 193 | 0.336 | |
| odontogenesis | GO:0042476 | 78 | 0.334 | |
| non canonical wnt signaling pathway via mapk cascade | GO:0038030 | 3 | 0.323 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.323 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.313 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.290 | |
| skeletal system development | GO:0001501 | 356 | 0.286 | |
| neural tube development | GO:0021915 | 160 | 0.285 | |
| epithelial tube formation | GO:0072175 | 130 | 0.279 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.273 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.264 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.258 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.257 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.256 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.240 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.232 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.224 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.217 | |
| synapse organization | GO:0050808 | 125 | 0.214 | |
| ossification | GO:0001503 | 216 | 0.211 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.211 | |
| cell growth | GO:0016049 | 130 | 0.207 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.200 | |
| action potential | GO:0001508 | 78 | 0.200 | |
| epithelial cell development | GO:0002064 | 159 | 0.197 | |
| positive regulation of rho gtpase activity | GO:0032321 | 41 | 0.194 | |
| protein localization to membrane | GO:0072657 | 108 | 0.193 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.192 | |
| forebrain development | GO:0030900 | 302 | 0.189 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.184 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.181 | |
| non canonical wnt signaling pathway via jnk cascade | GO:0038031 | 3 | 0.170 | |
| primary neural tube formation | GO:0014020 | 95 | 0.167 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.166 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.165 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.160 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.159 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.157 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.156 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.156 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.153 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.152 | |
| asymmetric neuroblast division | GO:0055059 | 1 | 0.152 | |
| regulation of transforming growth factor beta2 production | GO:0032909 | 2 | 0.151 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.149 | |
| positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000081 | 1 | 0.149 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.147 | |
| fibroblast growth factor receptor signaling pathway | GO:0008543 | 46 | 0.145 | |
| neural tube formation | GO:0001841 | 108 | 0.143 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.141 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.139 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.138 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.138 | |
| pallium development | GO:0021543 | 120 | 0.136 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.135 | |
| mapk cascade | GO:0000165 | 281 | 0.134 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.133 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.133 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.133 | |
| hindbrain formation | GO:0021576 | 1 | 0.131 | |
| cell adhesion | GO:0007155 | 329 | 0.130 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.128 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.128 | |
| cell maturation | GO:0048469 | 127 | 0.125 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.123 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.123 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.123 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.120 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.120 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.120 | |
| positive regulation of osteoblast differentiation | GO:0045669 | 34 | 0.119 | |
| neuron projection guidance | GO:0097485 | 141 | 0.118 | |
| microtubule based process | GO:0007017 | 236 | 0.112 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.111 | |
| response to growth factor | GO:0070848 | 198 | 0.111 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.110 | |
| glutamate receptor signaling pathway | GO:0007215 | 35 | 0.110 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.109 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 37 | 0.107 | |
| synaptic transmission | GO:0007268 | 329 | 0.107 | |
| tube formation | GO:0035148 | 140 | 0.106 | |
| mesonephric duct formation | GO:0072181 | 2 | 0.103 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.103 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.102 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.100 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.100 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.099 | |
| urogenital system development | GO:0001655 | 261 | 0.098 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.098 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.098 | |
| cell division | GO:0051301 | 120 | 0.097 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.096 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.096 | |
| regulation of cell growth | GO:0001558 | 91 | 0.096 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.094 | |
| stem cell differentiation | GO:0048863 | 268 | 0.094 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.093 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.093 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.092 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.092 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.092 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.091 | |
| type b pancreatic cell proliferation | GO:0044342 | 10 | 0.091 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.090 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.089 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.088 | |
| cell fate commitment | GO:0045165 | 210 | 0.087 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.087 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.087 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.087 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.086 | |
| germ cell development | GO:0007281 | 185 | 0.086 | Mouse |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.086 | |
| gtp catabolic process | GO:0006184 | 143 | 0.086 | |
| stem cell maintenance | GO:0019827 | 130 | 0.086 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.085 | |
| kidney development | GO:0001822 | 213 | 0.085 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.085 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.085 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.085 | |
| regulation of testosterone biosynthetic process | GO:2000224 | 2 | 0.085 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.084 | |
| memory | GO:0007613 | 58 | 0.084 | |
| transmembrane transport | GO:0055085 | 412 | 0.084 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.083 | |
| regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000079 | 1 | 0.082 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.082 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.082 | |
| planar cell polarity pathway involved in heart morphogenesis | GO:0061346 | 3 | 0.082 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.082 | |
| neuron death | GO:0070997 | 154 | 0.081 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.081 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.081 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.080 | |
| regulation of axon guidance | GO:1902667 | 13 | 0.079 | |
| response to fibroblast growth factor | GO:0071774 | 47 | 0.079 | |
| glucose homeostasis | GO:0042593 | 128 | 0.079 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.078 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.078 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.078 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.078 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.078 | |
| positive regulation of ras gtpase activity | GO:0032320 | 65 | 0.078 | |
| membrane organization | GO:0061024 | 245 | 0.078 | |
| male gamete generation | GO:0048232 | 285 | 0.076 | Mouse |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.076 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.076 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.076 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.075 | |
| cognition | GO:0050890 | 149 | 0.075 | |
| regulation of ossification | GO:0030278 | 112 | 0.074 | |
| dendritic spine development | GO:0060996 | 30 | 0.074 | |
| locomotory behavior | GO:0007626 | 195 | 0.073 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.073 | |
| angiogenesis | GO:0001525 | 201 | 0.073 | |
| spermatid development | GO:0007286 | 108 | 0.073 | Mouse |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.073 | |
| pancreas development | GO:0031016 | 57 | 0.073 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.073 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.073 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.072 | |
| transforming growth factor beta2 production | GO:0032906 | 2 | 0.072 | |
| neural tube closure | GO:0001843 | 90 | 0.072 | |
| outer medullary collecting duct development | GO:0072060 | 1 | 0.071 | |
| tube closure | GO:0060606 | 91 | 0.071 | |
| midbrain hindbrain boundary maturation | GO:0021732 | 1 | 0.071 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.071 | |
| gtp metabolic process | GO:0046039 | 144 | 0.071 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.070 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.069 | |
| renal system development | GO:0072001 | 225 | 0.069 | |
| oocyte differentiation | GO:0009994 | 35 | 0.069 | |
| regulation of voltage gated calcium channel activity | GO:1901385 | 4 | 0.068 | |
| regionalization | GO:0003002 | 337 | 0.068 | |
| axon ensheathment | GO:0008366 | 76 | 0.068 | |
| telencephalon development | GO:0021537 | 186 | 0.068 | |
| central nervous system neuron development | GO:0021954 | 67 | 0.067 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.067 | |
| loop of henle development | GO:0072070 | 10 | 0.067 | |
| dendritic spine organization | GO:0097061 | 26 | 0.067 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.066 | |
| cation transport | GO:0006812 | 399 | 0.066 | |
| regulation of cell cell adhesion mediated by cadherin | GO:2000047 | 2 | 0.066 | |
| glial cell differentiation | GO:0010001 | 131 | 0.066 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.066 | |
| limbic system development | GO:0021761 | 72 | 0.066 | |
| nephric duct formation | GO:0072179 | 4 | 0.065 | |
| foregut regionalization | GO:0060423 | 3 | 0.065 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.065 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.064 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.064 | |
| dendrite development | GO:0016358 | 115 | 0.064 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.063 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.063 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.063 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.063 | |
| cellular homeostasis | GO:0019725 | 240 | 0.063 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.062 | |
| cell cell junction organization | GO:0045216 | 72 | 0.062 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.061 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.061 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.061 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.061 | |
| regulation of ion transport | GO:0043269 | 215 | 0.061 | |
| establishment of organ orientation | GO:0048561 | 1 | 0.060 | |
| response to steroid hormone | GO:0048545 | 56 | 0.060 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.060 | |
| wnt signaling pathway planar cell polarity pathway | GO:0060071 | 27 | 0.060 | |
| jnk cascade | GO:0007254 | 72 | 0.060 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.059 | |
| regulation of secretion | GO:0051046 | 274 | 0.059 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.059 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.058 | |
| chemotaxis | GO:0006935 | 247 | 0.058 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.058 | |
| camera type eye development | GO:0043010 | 266 | 0.058 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.057 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.057 | |
| negative regulation of cell projection organization | GO:0031345 | 56 | 0.057 | |
| cop9 signalosome assembly | GO:0010387 | 2 | 0.056 | |
| synapse assembly | GO:0007416 | 56 | 0.056 | |
| gliogenesis | GO:0042063 | 141 | 0.056 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.055 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.055 | |
| axon guidance | GO:0007411 | 141 | 0.055 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.054 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.054 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.054 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.054 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.054 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.054 | |
| negative regulation of cell growth | GO:0030308 | 44 | 0.053 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.053 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.053 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.053 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.053 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.053 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.053 | |
| peptide secretion | GO:0002790 | 114 | 0.052 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.052 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.052 | |
| biomineral tissue development | GO:0031214 | 64 | 0.052 | |
| parathyroid hormone secretion | GO:0035898 | 2 | 0.051 | |
| regulation of neuron death | GO:1901214 | 134 | 0.051 | |
| positive regulation of anagen | GO:0051885 | 1 | 0.051 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.050 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.050 | |
| epithelium migration | GO:0090132 | 63 | 0.050 | |
| cerebellum formation | GO:0021588 | 1 | 0.050 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.050 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.050 | |
| protein catabolic process | GO:0030163 | 221 | 0.050 | |
| tooth mineralization | GO:0034505 | 9 | 0.049 | |
| establishment of planar polarity | GO:0001736 | 28 | 0.049 | |
| spermatogenesis | GO:0007283 | 284 | 0.049 | Mouse |
| epidermis development | GO:0008544 | 187 | 0.049 | |
| ubiquitin dependent smad protein catabolic process | GO:0030579 | 2 | 0.048 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.048 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.048 | |
| establishment of planar polarity involved in nephron morphogenesis | GO:0072046 | 1 | 0.048 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.048 | |
| embryonic genitalia morphogenesis | GO:0030538 | 4 | 0.048 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.047 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.047 | |
| regulation of system process | GO:0044057 | 200 | 0.047 | |
| skin morphogenesis | GO:0043589 | 38 | 0.047 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.047 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.047 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.046 | |
| regulation of axon extension | GO:0030516 | 43 | 0.046 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.045 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.045 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.045 | |
| diencephalon development | GO:0021536 | 63 | 0.045 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.045 | |
| multicellular organism growth | GO:0035264 | 161 | 0.045 | |
| leukocyte migration | GO:0050900 | 124 | 0.045 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.045 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.044 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.044 | |
| peripheral nervous system development | GO:0007422 | 53 | 0.044 | |
| neuronal action potential | GO:0019228 | 54 | 0.044 | |
| cerebral cortex development | GO:0021987 | 86 | 0.044 | |
| renal outer medulla development | GO:0072054 | 2 | 0.044 | |
| establishment of tissue polarity | GO:0007164 | 28 | 0.044 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.044 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.044 | |
| regulation of receptor activity | GO:0010469 | 41 | 0.044 | |
| lens morphogenesis in camera type eye | GO:0002089 | 24 | 0.044 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.043 | |
| semaphorin plexin signaling pathway involved in bone trabecula morphogenesis | GO:1900220 | 2 | 0.043 | |
| lung field specification | GO:0060424 | 3 | 0.043 | |
| antimicrobial peptide biosynthetic process | GO:0002777 | 2 | 0.043 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.043 | |
| gas homeostasis | GO:0033483 | 3 | 0.043 | |
| white fat cell proliferation | GO:0070343 | 2 | 0.043 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.043 | |
| calcium ion transport | GO:0006816 | 159 | 0.043 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.042 | |
| regulation of tumor necrosis factor superfamily cytokine production | GO:1903555 | 50 | 0.042 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.042 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.042 | |
| renal vesicle induction | GO:0072034 | 3 | 0.041 | |
| response to inorganic substance | GO:0010035 | 96 | 0.041 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.041 | |
| regulation of anagen | GO:0051884 | 1 | 0.041 | |
| bone mineralization | GO:0030282 | 54 | 0.041 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.041 | |
| compound eye development | GO:0048749 | 1 | 0.040 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.040 | |
| hair follicle development | GO:0001942 | 85 | 0.040 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.040 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.040 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.040 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.040 | |
| hippocampus development | GO:0021766 | 52 | 0.040 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.040 | |
| kidney rudiment formation | GO:0072003 | 3 | 0.040 | |
| hair follicle morphogenesis | GO:0031069 | 29 | 0.040 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.039 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.039 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.039 | |
| tissue migration | GO:0090130 | 68 | 0.039 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.039 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.038 | |
| sensory perception | GO:0007600 | 245 | 0.038 | |
| regulation of protein localization | GO:0032880 | 231 | 0.038 | |
| anion transport | GO:0006820 | 177 | 0.038 | |
| learning | GO:0007612 | 98 | 0.038 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.038 | |
| regulation of alpha amino 3 hydroxy 5 methyl 4 isoxazole propionate selective glutamate receptor activity | GO:2000311 | 11 | 0.038 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.038 | |
| dendritic spine morphogenesis | GO:0060997 | 22 | 0.038 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.038 | |
| midbrain hindbrain boundary maturation during brain development | GO:0022004 | 1 | 0.037 | |
| canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation | GO:0044343 | 1 | 0.037 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.037 | |
| negative regulation of testosterone biosynthetic process | GO:2000225 | 1 | 0.037 | |
| spemann organizer formation | GO:0060061 | 2 | 0.037 | |
| astrocyte differentiation | GO:0048708 | 43 | 0.037 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.037 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.037 | |
| regulation of binding | GO:0051098 | 111 | 0.037 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.037 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.037 | |
| negative regulation of growth | GO:0045926 | 99 | 0.037 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.037 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.037 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.036 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.036 | Mouse |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.036 | |
| regulation of auditory receptor cell differentiation | GO:0045607 | 4 | 0.036 | |
| gland development | GO:0048732 | 330 | 0.036 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.036 | |
| regulation of epidermis development | GO:0045682 | 33 | 0.036 | |
| embryonic heart tube morphogenesis | GO:0003143 | 51 | 0.036 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.035 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.035 | |
| positive regulation of endopeptidase activity | GO:0010950 | 43 | 0.035 | |
| uterus morphogenesis | GO:0061038 | 2 | 0.035 | |
| lung induction | GO:0060492 | 3 | 0.035 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.035 | |
| amino acid transport | GO:0006865 | 61 | 0.035 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.035 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.035 | |
| regulation of cell activation | GO:0050865 | 289 | 0.035 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.035 | |
| connective tissue development | GO:0061448 | 179 | 0.035 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.035 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.035 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.035 | |
| positive regulation of transforming growth factor beta2 production | GO:0032915 | 2 | 0.034 | |
| organic anion transport | GO:0015711 | 137 | 0.034 | |
| myelination | GO:0042552 | 74 | 0.034 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.034 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.034 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.034 | |
| response to light stimulus | GO:0009416 | 135 | 0.034 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.033 | |
| canonical wnt signaling pathway involved in regulation of cell proliferation | GO:0044340 | 3 | 0.033 | |
| negative regulation of cell morphogenesis involved in differentiation | GO:0010771 | 48 | 0.033 | |
| non canonical wnt signaling pathway involved in heart development | GO:0061341 | 3 | 0.033 | |
| inner medullary collecting duct development | GO:0072061 | 2 | 0.033 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.033 | |
| negative regulation of axon guidance | GO:1902668 | 8 | 0.033 | |
| extracellular structure organization | GO:0043062 | 148 | 0.033 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 1 | 0.033 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.032 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.032 | |
| adult behavior | GO:0030534 | 135 | 0.032 | |
| mesenchyme development | GO:0060485 | 152 | 0.032 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.032 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.032 | |
| neuroblast differentiation | GO:0014016 | 2 | 0.032 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.032 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.032 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.032 | |
| heart morphogenesis | GO:0003007 | 178 | 0.031 | |
| corpus callosum development | GO:0022038 | 10 | 0.031 | |
| regulation of gliogenesis | GO:0014013 | 50 | 0.031 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.031 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.031 | |
| lateral sprouting involved in mammary gland duct morphogenesis | GO:0060599 | 2 | 0.031 | |
| wnt signaling pathway calcium modulating pathway | GO:0007223 | 2 | 0.031 | |
| neuronal stem cell division | GO:0036445 | 10 | 0.031 | |
| regulation of epithelial to mesenchymal transition | GO:0010717 | 22 | 0.031 | |
| regulation of long term synaptic depression | GO:1900452 | 3 | 0.031 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.031 | |
| lung development | GO:0030324 | 164 | 0.031 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.031 | |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 | 26 | 0.030 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.030 | |
| actin filament organization | GO:0007015 | 113 | 0.030 | |
| establishment or maintenance of polarity of embryonic epithelium | GO:0016332 | 1 | 0.030 | |
| female gamete generation | GO:0007292 | 74 | 0.030 | |
| peptide transport | GO:0015833 | 133 | 0.030 | |
| spermatid differentiation | GO:0048515 | 115 | 0.030 | Mouse |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.030 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.030 | |
| regulation of cell motility | GO:2000145 | 236 | 0.030 | |
| regulation of defense response | GO:0031347 | 233 | 0.030 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.030 | |
| learning or memory | GO:0007611 | 148 | 0.030 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.029 | |
| ear development | GO:0043583 | 200 | 0.029 | |
| cerebellar cortex formation | GO:0021697 | 22 | 0.029 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.029 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.029 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.029 | |
| regulation of cell migration | GO:0030334 | 219 | 0.029 | |
| hindbrain development | GO:0030902 | 128 | 0.029 | |
| epithelial cell migration | GO:0010631 | 63 | 0.029 | |
| skin development | GO:0043588 | 220 | 0.029 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.028 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.028 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.028 | |
| regulation of establishment of planar polarity | GO:0090175 | 28 | 0.028 | |
| establishment of vesicle localization | GO:0051650 | 81 | 0.028 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.028 | |
| lymphocyte homeostasis | GO:0002260 | 64 | 0.028 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.028 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.028 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.028 | |
| nuclear division | GO:0000280 | 158 | 0.028 | |
| dephosphorylation | GO:0016311 | 129 | 0.028 | |
| regulation of neural retina development | GO:0061074 | 3 | 0.028 | |
| endothelial cell migration | GO:0043542 | 44 | 0.027 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.027 | |
| glial cell development | GO:0021782 | 54 | 0.027 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.027 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.027 | |
| cellular response to parathyroid hormone stimulus | GO:0071374 | 2 | 0.027 | |
| metanephric tubule development | GO:0072170 | 18 | 0.027 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.027 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.027 | |
| response to insulin | GO:0032868 | 100 | 0.027 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.027 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.027 | |
| regulation of ovulation | GO:0060278 | 3 | 0.027 | |
| oocyte axis specification | GO:0007309 | 2 | 0.027 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.027 | |
| regulation of jnk cascade | GO:0046328 | 62 | 0.027 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.027 | |
| digestion | GO:0007586 | 40 | 0.026 | |
| regulation of glutamate receptor signaling pathway | GO:1900449 | 16 | 0.026 | |
| protein processing | GO:0016485 | 163 | 0.026 | |
| organelle fission | GO:0048285 | 170 | 0.026 | |
| antimicrobial peptide production | GO:0002775 | 2 | 0.026 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.026 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.026 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.026 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.026 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.026 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.026 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.026 | |
| metencephalon development | GO:0022037 | 89 | 0.026 | |
| cervix development | GO:0060067 | 2 | 0.026 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.026 | |
| midgut development | GO:0007494 | 4 | 0.025 | |
| cellular response to fibroblast growth factor stimulus | GO:0044344 | 47 | 0.025 | |
| cerebellum development | GO:0021549 | 77 | 0.025 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.025 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.025 | |
| paramesonephric duct development | GO:0061205 | 3 | 0.025 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.025 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.025 | |
